SEC Form 4 · accession 0001179110-17-015854
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin F Jackson
Officer — Executive Vice President
Period of report
Dec 20, 2017
Accepted (ET)
Dec 22, 2017 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2017 | S | 323 | $17.05 | D | 1,717,944 | D | |
| Common StockF1 | Dec 21, 2017 | S | 71,757 | $17.05 | D | 1,646,187 | D | |
| Common StockF1 | Dec 22, 2017 | S | 61,949 | $17.05 | D | 1,584,238 | D | |
| Common StockF2 | holding | — | — | — | 2,634 | I | By son | |
| Common StockF2 | holding | — | — | — | 2,634 | I | By son | |
| Common StockF2 | holding | — | — | — | 2,634 | I | By daughter | |
| Common StockF2 | holding | — | — | — | 2,634 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.05 to $17.08, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.